--------------------------------------------------------------------------------------
From: Pontani, Dennis
Sent: Tuesday, November 21, 2006 11:23 PM
To: [Doctor name redacted]
Cc: [Sales rep name redacted]
Subject: RE: Maraviroc EAP Clinical Study
Dr. [Name redacted],
I am the field-based medical director for Pfizer's HIV portfolio, which includes Viracept and soon to be new product, Maraviroc. I was hoping to discuss our EAP program with you on my next visit December 7th but just wanted to provide you with a quick overview.
This EAP is being run as a clinical trial, will enroll up to 6000 patients worldwide and will provide supplemental safety data to the FDA.
Investigators will be paid $1200 for each patient enrolled and also provided with financial support for the IRB process. All screened patients will need a tropism assay (only R5 tropic patients will be included) which will be paid by Pfizer.
If you would like more information and/or can meet on December [redacted] please let me know.
I look forward to working with you in the future,
Best regards,
Dennis Pontani, MS, PhD
Regional Medical Director, HIV Team
Pfizer Inc
--------------------------------------------------------------------------------------
From: Pontani, Dennis
Sent: Tuesday, November 21, 2006 11:40 PM
To: [Doctor name redacted]
Cc: [Sales rep name redacted]
Subject: Visit
[Doctor name redacted],
I just wanted to thank you for the time to discuss Maraviroc and our EAP program. I hope that you will be able to have this trial set up in your institution. Please let me know if there is anything else I can provide.
Best regards,
Dennis
--------------------------------------------------------------------------------------
From: Pontani, Dennis
Sent: Tuesday, November 21, 2006 11:23 PM
To: [Doctor name redacted]
Cc: [Sales rep name redacted]
Subject: RE: Maraviroc EAP Clinical Study
Dr. [Name redacted],
I am the field-based medical director for Pfizer's HIV portfolio, which includes Viracept and soon to be new product, Maraviroc. I was hoping to discuss our EAP program with you on my next visit December 7th but just wanted to provide you with a quick overview.
Investigators will be paid $1200 for each patient enrolled and also provided with financial support for the IRB process. All screened patients will need a tropism assay (only R5 tropic patients will be included) which will be paid by Pfizer.
If you would like more information and/or can meet on December [redacted] please let me know.
I look forward to working with you in the future,
Best regards,
Dennis Pontani, MS, PhD
Regional Medical Director, HIV Team
Pfizer Inc
--------------------------------------------------------------------------------------
From: Pontani, Dennis
Sent: Tuesday, November 21, 2006 11:40 PM
To: [Doctor name redacted]
Cc: [Sales rep name redacted]
Subject: Visit
[Doctor name redacted],
I just wanted to thank you for the time to discuss Maraviroc and our EAP program. I hope that you will be able to have this trial set up in your institution. Please let me know if there is anything else I can provide.
Best regards,
Dennis
--------------------------------------------------------------------------------------
Next Page 1 | 2 | 3 | 4 | 5 | 6 | 7
(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).
